Previous 10 | Next 10 |
AB201 being developed as a potential treatment for COVID-19 and other RNA virus associated diseases ARCA anticipates filing an IND for AB201 in Q3 2020 and initiating Phase 2 clinical testing in Q4 2020 WESTMINSTER, Colo., Aug. 05, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc...
Sonoma Pharmaceuticals (NASDAQ: SNOA ) +82% on potential of disinfectant/sanitizer in airline industry. More news on: Sonoma Pharmaceuticals, Inc., Eastman Kodak Company, Heat Biologics, Inc., Stocks on the move, , Read more ...
AC Immune (NASDAQ: ACIU ) +76% on advancement of Alzheimer's vaccine study. More news on: AC Immune SA, Future FinTech Group Inc., Boxlight Corporation, Stocks on the move, , Read more ...
Document Security Systems (NYSEMKT: DSS ) +69% after its target acquisition Company, Impact Biomedical reports positive results of equivir and linebacker for treatment of COVID-19. More news on: Document Security Systems, Inc., Infinity Pharmaceuticals, Inc., Dolphin Entertainment...
Integrin A5 may be a new target for intervening in the cell infectious process Findings may lead to the development of precision therapeutic approaches to prevent SARS-CoV-2-cell entry while preserving the functional activity of ACE2 WESTMINSTER and AURORA, Colo., July 07, 2020 (GLOBE...
WESTMINSTER, Colo., June 03, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) a late stage biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced the closing of its previously a...
Gainers: Cemtrex (NASDAQ: CETX ) +209% . More news on: Cemtrex, Inc., Digital Ally, Inc., Allied Esports Entertainment Inc., Stocks on the move, , Read more ...
ARCA biopharma (NASDAQ: ABIO ) has entered into a definitive securities purchase agreement with certain investors to purchase, in a registered direct offering, 348,000 common shares at $9.00/share, and pre-funded warrants to purchase 694,222 common shares $8.999/warrant, for expected ...
Edwards Lifesciences (NYSE: EW ) -66% . More news on: Edwards Lifesciences Corporation, Iterum Therapeutics plc, Novus Therapeutics, Inc., Stocks on the move, , Read more ...
WESTMINSTER, Colo., June 01, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) a late stage biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that it has entered into a defi...
News, Short Squeeze, Breakout and More Instantly...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Bank of the James Financial Group Inc. (BOTJ) is expected to report for Q2 2024 Electrolux AB ADR (ELUXY) is expected to report $-0.18 for Q2 2024 Coca Cola Femsa S.A.B. de C.V. American Depositary Shares each representing 10 Units (each Unit consists of 3 Series B Shares and 5 Series L S...
NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sale...